Browsing by Subject "Intrauterine exposure"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    HEAD CIRCUMFERENCE AS PREDICTED BY FACIAL MEASURES IN MOUSE MODEL OF FASD
    (Office of the Vice Chancellor for Research, 2012-04-13) Timm, Floyd A.; Ward, Richard E.; Wetherill, Leah; Ai, Huisi; Shen, Li; Anthony, Bruce; Zhou, Feng C.
    Intrauterine exposure to ethanol produces a myriad of anomalies, many tied to the developing brain. Both dose and duration of exposure are suggested to have cumulative effects on brain growth; however, brain volume is difficult to obtain directly, so a commonly used indirect measure of brain volume has been the occipital frontal circumference (OFC) in humans (Malina and Bouchard). In this study, we investigated the relationship of craniofacial measurements and exposure histories against skull circumference in C57BL/6J (Jackson Laboratory) mice. Three alcohol treatment groups were used, which differed in dose of alcohol administered and/or the duration of treatment during gestation. All pups were surrogated at birth with normal dams and received microCT at postnatal day (P) 21. Individual measurement comparisons were made between treatment groups, a control sample of chow fed, and matching groups of pair-fed (isocalorically linked liquid diet). Linear craniofacial measurements were derived from micro-CT images, and a measure of head circumference was constructed using the MxView software (Philips). A multiple linear regression was used to evaluate the facial measurements that best predicted circumference. Variables explored were facial measurements as well as treatment and gender. The model, using a constant, mid facial depth, inner orbital width, and bigonial width predicted 68.8% of variance in circumference (N=164, R2=.688, p=.006). In conclusion, a small set of facial measurements can moderately predict circumference in mice. However, in a small exploratory study, there is an indication that alcohol exposure is a significant factor in the degree to which circumference relates to total brain volume. 2Department of Anthropology Indiana University Purdue University Indianapolis, Indianapolis, Indiana, 46202 3Medical and Molecular Genetics, Indiana University School of Medicine Indianapolis, Indiana, 46202 4Department of Radiology and Imaging Sciences Indiana University School of Medicine, Indianapolis, IN 46202 5Stark Neuroscience Research Institute, Indiana University School of Medicine Indianapolis, Indiana, 46202
  • Thumbnail Image
    Item
    Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy
    (Oxford University Press, 2015-09-15) Siberry, George K.; Jacobson, Denise L.; Kalkwarf, Heidi J.; Wu, Julia W.; DiMeglio, Linda A.; Yogev, Ram; Knapp, Katherine M.; Wheeler, Justin J.; Butler, Laurie; Hazra, Rohan; Miller, Tracie L.; Seage III, George R.; Van Dyke, Russell B.; Barr, Emily; Davtyan, Mariam; Mofenson, Lynne M.; Rich, Kenneth C.; Department of Pediatrics, IU School of Medicine
    BACKGROUND: Fetal bone effects of maternal tenofovir use have not been well studied. We sought to compare whole-body bone mineral content (BMC) of newborns exposed vs not exposed to tenofovir in utero. METHODS: We enrolled participants from April 2011 to June 2013 at 14 US clinical sites. Singleton infants of women with human immunodeficiency virus (HIV) infection who took tenofovir in late pregnancy (tenofovir-exposed) or no tenofovir during pregnancy (tenofovir-unexposed) were enrolled during late pregnancy or within 72 hours of birth. Infants born before 36 weeks gestation or with confirmed HIV infection were excluded. Whole-body BMC was measured in the first month of life and compared with that of the tenofovir-exposed and tenofovir-unexposed newborns, unadjusted and adjusted for covariates. RESULTS: Seventy-four tenofovir-exposed and 69 tenofovir-unexposed infants had evaluable BMC measurements. Tenofovir-exposed mothers were more likely to be married (31% vs 22%; P = .04) and to use boosted protease inhibitors (84% vs 62%; P = .004). Tenofovir-exposed newborns did not differ from unexposed newborns on mean gestational age (38.2 vs 38.1 weeks) or mean length (-0.41 vs -0.18) or weight (-0.71 vs -0.48) Z-scores. The mean (standard deviation) BMC of tenofovir-exposed infants was 12% lower than for unexposed infants (56.0 [11.8] vs 63.8 [16.6] g; P = .002). The adjusted mean bone mineral content was 5.3 g lower (95% confidence interval, -9.5, -1.2; P = .013) in the tenofovir-exposed infants. CONCLUSIONS: Maternal tenofovir use is associated with significantly lower neonatal BMC. The duration and clinical significance of this finding should be evaluated in longitudinal studies.